Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective

Monoclonal Antibody Therapy of Pancreatic Cancer With Cetuximab

(2012) Eric Luedke et al.   JOURNAL OF IMMUNOTHERAPY

Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study

(2012) Tudor Ciuleanu et al.   LANCET ONCOLOGY

Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities

(2011) Mario E. Lacouture et al.   SUPPORTIVE CARE IN CANCER

Skin Toxicity Evaluation Protocol With Panitumumab (STEPP), a Phase II, Open-Label, Randomized Trial Evaluating the Impact of a Pre-Emptive Skin Treatment Regimen on Skin Toxicities and Quality of Life in Patients With Metastatic Colorectal Cancer

(2010) Mario E. Lacouture et al.   JOURNAL OF CLINICAL ONCOLOGY

A prospective randomized trial of topical pimecrolimus for cetuximab-associated acne-like eruption

(2009) Alon Scope et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes

(2008) Aminah Jatoi et al.   CANCER